Table 2.

Comparison of the Clinical Features between Patients with and without Rebleeding

Data are presented as mean±SD or number (%).

BMI, body mass index; NSAIDs, nonsteroidal anti-inflammatory drugs; AB, actively bleeding; NBVV, nonbleeding visible vessel; DAC, densely adherent clot; TAE, transcatheter arterial embolization.